Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas

Brain Pathology

Volumn 14, Issue 4, 2004, Pages 399-405

  Neder, Luciano ^a   Nagahashi Marie, Suely K ^a   Carlotti Jr , Carlos Gilberto ^a   Gabbai, Alberto Alain ^b   Rosemberg, Sérgio ^a   Malheiros, Suzana M F ^b   Siqueira, Rodrigo Proto ^a   Oba Shinjo, Sueli Mieko ^a   Uno, Miyuki ^a   Aguiar, Paulo Henrique ^a   Miura, Flavio ^a   Chammas, Roger ^a   Colli, Benedicto Oscar ^a   Silva Jr , Wilson Araujo ^a   Zago, Marco A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3;

ADULT; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; REAL TIME POLYMERASE CHAIN REACTION;

EID: 8744224531     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2004.tb00083.x     Document Type: Article

References (51)

1. Almkvist J, Karlsson A (2004) Galectins as inflammatory mediators. Glycoconj J 19:575-581.
2. Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Lui F, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PW, Rini JM, Wang JL (1994b) Galectins: a family of animal β-galactoside-binding lectins. Cell 76:597-598.
3. Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Meir EGV (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920-927.
4. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80:776-787.
5. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotqui J, Zick Y, Salmon I, Gabius HJ, Kiss R (2001) Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and modulate tumor astrocyte migration. Brain Pathol 11:12-26.
6. Cooper DNW, Barondes SH (1999) God must love galectins; he made so many of them. Glycobiology 9:919-984.
7. Cowles EA, Agrwal N, Anderson RL, Wang JL (1990) Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J Biol Chem 265:17706-17712.
8. Danguy A, Camby I, Kiss R (2002) Galectins and cancer. Biochem Biophys Acta 1572:285-293.
9. Daumas-Duport C, Beuvon F, Varlet P, Fallet-Bianco C (2000) Gliomas: WHO and Sainte-Anne Hospital classifications. Ann Pathol 20:413-428.
10. Deininger MH, Trautmann K, Meyermann R, Schluesener HJ (2002) Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. Anticancer Res 22:1585-1592.
11. Engelhard HH, Stelea A, Cochran EJ (2002) Oligodendroglioma: pathology and molecular biology. Surg Neurol 58:111-117.
12. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, Raz A (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63:8302-8311.
13. Gallo V, Armstrong RC (1995) Developmental and growth factor-induced regulation of nestin in oligodendrocyte lineage cells. J Neurosci 15:394-406.
14. Geiger KD, Stoldt P, Schlote W, Derouiche A (2000) Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas. Am J Pathol 157:1785-1793.
15. Goletz S, Hanisch FG, Karsten U (1997) Novel alphaGalNAc containing glycans on cytokeratins are recognized in vitro by galectins with type II carbohydrate recognition domains. J Cell Sci 110:1585-1596.
16. Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M, Danguy A, Gabius HJ, Salmon I, Kiss R, Camby I (1999) Galectin and galectin-3 binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Applied Neurobiol 25:319-330.
17. Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986-994.
18. Hirabayashi J, Kasai K (1993) The family of metazoan metal-independent (-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology 3:297-304.
19. Hoang-Xuan K, Aguirre-Cruz L, Mokhtari K, Marie Y, Sanson M (2002) OLIG-I and 2 gene expression and oligodendroglial tumours. Neuropathol Appl Neurobiol 28:89-94.
20. Hughes RC (1997) The galectin family of mammalian carbohydrate-binding molecules. Biochem Soc Trans 25:1194-1198.
21. Hughes RC (2001) Galectins as modulator of cell adhesion. Biochemie 83:667-676.
22. Inohara H, Akahani S, Raz A (1998) Galectin-3 stimulates cell proliferation. Exp Cell Res 245:294-302.
23. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225.
24. Kuklinski S, Pesheva P, Heimann C, Urschel S, Gloor S, Graeber S, Herzog V, Pietsch T, Wiestler OD, Probstmeier R (2000) Expression pattern of galectin-3 in neural tumor cell lines. J Neurosci Res 60: 45-57.
25. Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL (1994) Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj J 11:462-468.
26. Liu FT, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochem Biophys Acta 1572:263-273.
27. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods 2S:402-408.
28. Lu QR, Park JK, Noll E, Chan JA, Alberta J, Yuk D, Alzamora MG, Louis DN, Stiles CD, Rowitch DH, Black PM (2001) Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci U S A 98:10851-10856.
29. Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K (2001 ) OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 358:298-300.
30. Menon RP, Strom M, Hughes RC (2000) Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner. FEBS Lett 470:227-231.
31. Nakagawa Y, Perentes E, Rubinstein LJ (1986) Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers. Acta Neuropathol (Berl) 72:15-22.
32. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 156:899-909.
33. Ohnishi A, Sawa H, Tsuda M, Sawamura Y, Itoh T, Iwasaki Y, Nagashima K (2003) Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 62:1052-1059.
34. Ochieng, J, Leite-Browning ML, Warfield P (1998) Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Comm 246:788-791.
35. Park JW, Voss PG, Grabski S, Wang JL, Patterson RJ (2001) Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Res 29:3595-3602.
36. Perentes E, Rubinstein LJ (1986) Immunohistochemical recognition of human neuroepithelial tumors by anti-Leu 7 (HNK-1) monoclonal antibody. Acta Neuropathol (Berl) 69:227-233.
37. Perillo NL, Marcus ME, Baum LG (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76:402-412.
38. Pohl U, Cairncross JG, Louis DN (1999) Homozygous deletions of the CDKN2C/p18INK4C gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas. Brain Pathol 9:639-643.
39. Probstemeier R, Montag D, Schachner M (1995) Galectin-3, a beta-galactoside-binding animal lectin, binds to neural recognition molecules. J Neurochem 64:2465-2472.
40. Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, Jaeckle KA, Yung WK, Buys SS, Bruner JM, Townsend JJ, Davis R, Sawaya R, Kyritsis AP (2003) Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 65:259-266.
41. Rabinovich GA (1999) Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ 6:711-721.
42. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23:313-320.
43. Riemenschneider MJ, Koy TH, Reifenberger G (2004) Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas. Acta Neuropathol (Berl) 107:277-282.
44. Rutka JT, Apodaca G, Stern R, Rosenblum M (1998) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69:155-170.
45. Sato S, Hughes RC (1992) Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 267:6983-6990.
46. Seve AP, Felin M, Doyennette-Moyne MA, Sahraoui T, Aubery M, Hubert J (1993) Evidence for a lactose-mediated association between two nuclear carbohydrate-binding proteins. Glycobiology 3:23-30.
47. Strik HM, Deininger MH, Frank B, Schluesener HJ, Meyermann R (2001) Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas. J Neurooncol 53:13-20.
48. van den Bent MJ, Chinot O, Boogerd W, Bravo Marques J, Taphoorn MJ, Kros JM, van der Rijt CC, Vecht CJ, De Beule N, Baron B (2003) Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. Ann Oncol 14:599-602.
49. Yang RY, Hsu DK, Liu FT (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93:6737-6742.
50. Yang RY, Liu FT (2003) Galectins in cell growth and apoptosis. Cell Mol Life Sci 60:267-276.
51. Yates AJ, Comas T, Scheithauer BW, Burger PC, Pearl DK (1999) Glycolipid markers of astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurol 58:1250-1262.